Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Generics Bulletin

Medtech Insight

Sentinel May Expand To Generic Equivalence Studies

Feb 15 2017

• By Derrick Gingery

Related Content

FDA Generics Research Forges Ahead After Agency’s Bupropion Mea Culpa

Dec 10 2012

Sentinel Offers Drug Firms ‘Unique’ Venue For Post-Market Studies, Pfizer Says

Feb 05 2017

FDA Bioequivalence Study On Metoprolol Shows Emerging Generic Investigation Strategy

May 08 2014

Generic Labeling Rule Becomes Statistical Battle As Public Meeting Looms

Mar 26 2015

FDA Aims To Tap Sentinel Data Network For Drug Effectiveness Studies

Feb 08 2016

Reagan-Udall, Pfizer Testing Ways To Tap Sentinel Network Without FDA

May 15 2015

Complex ANDAs To Be Allowed Pre-Submission Product Meetings

Oct 24 2016

ANDA Approval Speed-Up Leaves Sponsors With Less Margin For Error

May 30 2016

Sentinel’s “IMPACT” Beyond Safety: Anti-Coagulant Study Is Early Test

Mar 10 2016

Related Companies

AstraZeneca PLC

GSK plc

Novartis AG

AMAG Pharmaceuticals Inc.

Additional Topics

United States Generic Drugs Safety Regulation BioPharmaceutical

More from Generics

More from Products

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window